Long Non-coding RNA Double Homeobox A Pseudogene 8: A Novel Oncogenic Propellant in Human Cancer

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Oct 11

PMID 34631702

Citations 4

Authors

Chen Xue

Xiaolu Cai

Junjun Jia

Affiliations

Soon will be listed here.

Abstract

A growing number of studies are reporting important roles played by long non-coding RNAs (lncRNAs) in various pathological and physiological processes. LncRNAs are implicated in numerous genomic regulatory functions at different levels, including regulation of transcription, post-transcriptional processes, genomic stability, and epigenetic genome modifications. Double homeobox A pseudogene 8 (DUXAP8), a novel lncRNA, has been reported to be involved in many cancers, including gastric, colorectal, esophageal, bladder, oral, ovarian, lung, and pancreatic cancers as well as hepatocellular carcinoma (HCC). DUXAP8 plays specific oncogenic roles numerous malignancies promoting pathways. DUXAP8 is frequently dysregulated in multiple cancers, acting as a sponge to downregulate various tumor-suppressing microRNA activities. In this review, we comprehensively explore DUXAP8 expression and prognosis across cancer types, and systematically summarize current evidence concerning the functions and molecular mechanisms of DUXAP8 in tumorigenesis and progression. We conclude that DUXAP8 is a potential biomarker and therapeutic target for multiple cancers.

Citing Articles

Construction of an oxidative stress-related lncRNAs signature to predict prognosis and the immune response in gastric cancer.

Zhang H, Feng H, Yu T, Zhang M, Liu Z, Ma L Sci Rep. 2023; 13(1):8822.

PMID: 37258567 PMC: 10232468. DOI: 10.1038/s41598-023-35167-8.

An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer affecting immune cell infiltration landscape.

Xiong S, Jin L, Zeng C, Ma H, Xie L, Liu S Pathol Oncol Res. 2022; 28:1610712.

PMID: 36567977 PMC: 9767988. DOI: 10.3389/pore.2022.1610712.

Bioinformatics analysis constructs potential ferroptosis-related ceRNA network involved in the formation of intracranial aneurysm.

Zhu H, Tan J, Wang Z, Wu Z, Zhou W, Zhang Z Front Cell Neurosci. 2022; 16:1016682.

PMID: 36313616 PMC: 9612944. DOI: 10.3389/fncel.2022.1016682.

A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.

Hu J, Lai C, Shen Z, Yu H, Lin J, Xie W Front Oncol. 2022; 12:833763.

PMID: 35280814 PMC: 8913725. DOI: 10.3389/fonc.2022.833763.

References

Darbellay F, Necsulea A . Comparative Transcriptomics Analyses across Species, Organs, and Developmental Stages Reveal Functionally Constrained lncRNAs. Mol Biol Evol. 2019; 37(1):240-259. PMC: 6984365. DOI: 10.1093/molbev/msz212. View

Chen M, Zheng Y, Xie J, Zhen E, Zhou X . Integrative profiling analysis identifies the oncogenic long noncoding RNA DUXAP8 in oral cancer. Anticancer Drugs. 2020; 31(8):792-798. DOI: 10.1097/CAD.0000000000000936. View

Stoklosa P, Borgstrom A, Kappel S, Peinelt C . TRP Channels in Digestive Tract Cancers. Int J Mol Sci. 2020; 21(5). PMC: 7084354. DOI: 10.3390/ijms21051877. View

Goodall G, Wickramasinghe V . RNA in cancer. Nat Rev Cancer. 2020; 21(1):22-36. DOI: 10.1038/s41568-020-00306-0. View

Elkon R, Agami R . Characterization of noncoding regulatory DNA in the human genome. Nat Biotechnol. 2017; 35(8):732-746. DOI: 10.1038/nbt.3863. View

Nie L, Li C, Zhao T, Wang Y, Liu J . LncRNA double homeobox A pseudogene 8 (DUXAP8) facilitates the progression of neuroblastoma and activates Wnt/β-catenin pathway via microRNA-29/nucleolar protein 4 like (NOL4L) axis. Brain Res. 2020; 1746:146947. DOI: 10.1016/j.brainres.2020.146947. View

Okugawa Y, Grady W, Goel A . Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology. 2015; 149(5):1204-1225.e12. PMC: 4589488. DOI: 10.1053/j.gastro.2015.07.011. View

Hu Y, Zhang X, Zai H, Jiang W, Xiao L, Zhu Q . lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1. Mol Ther Oncolytics. 2020; 19:308-322. PMC: 7701012. DOI: 10.1016/j.omto.2020.10.010. View

Chen J, Lou W, Ding B, Wang X . Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers. Aging (Albany NY). 2019; 11(15):5666-5688. PMC: 6710046. DOI: 10.18632/aging.102152. View

10.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

11.

Lian Y, Yang J, Lian Y, Xiao C, Hu X, Xu H . DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2. Cancer Commun (Lond). 2018; 38(1):64. PMC: 6235391. DOI: 10.1186/s40880-018-0333-9. View

12.

Xu L, Yu X, Wei B, Hui H, Sun Y, Dai J . Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer. Eur Rev Med Pharmacol Sci. 2018; 22(9):2646-2652. DOI: 10.26355/eurrev_201805_14959. View

13.

Huang Z, Zhou J, Peng Y, He W, Huang C . The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020; 19(1):77. PMC: 7161154. DOI: 10.1186/s12943-020-01188-4. View

14.

He W, Yu Y, Huang W, Feng G, Li J . The Pseudogene DUXAP8 Promotes Colorectal Cancer Cell Proliferation, Invasion, and Migration by Inducing Epithelial-Mesenchymal Transition Through Interacting with EZH2 and H3K27me3. Onco Targets Ther. 2020; 13:11059-11070. PMC: 7605666. DOI: 10.2147/OTT.S235643. View

15.

Yang X, Liu M, Li M, Zhang S, Hiju H, Sun J . Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology. Mol Cancer. 2020; 19(1):64. PMC: 7092482. DOI: 10.1186/s12943-020-01159-9. View

16.

Ma H, Xie M, Sun M, Chen T, Jin R, Ma T . The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression. Oncotarget. 2017; 8(32):52211-52224. PMC: 5581023. DOI: 10.18632/oncotarget.11075. View

17.

Pilleron S, Sarfati D, Janssen-Heijnen M, Vignat J, Ferlay J, Bray F . Global cancer incidence in older adults, 2012 and 2035: A population-based study. Int J Cancer. 2018; 144(1):49-58. DOI: 10.1002/ijc.31664. View

18.

Liu Y, Zhang G, Chen H, Wang H . Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p. Biosci Rep. 2020; 41(1). PMC: 7791543. DOI: 10.1042/BSR20200884. View

19.

Zhai W, Sun Y, Guo C, Hu G, Wang M, Zheng J . LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals. Cell Death Differ. 2017; 24(9):1502-1517. PMC: 5563985. DOI: 10.1038/cdd.2017.74. View

20.

Loewen G, Jayawickramarajah J, Zhuo Y, Shan B . Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014; 7:90. PMC: 4266198. DOI: 10.1186/s13045-014-0090-4. View